Literature DB >> 33532912

Wide distribution of prion infectivity in the peripheral tissues of vCJD and sCJD patients.

Jean-Yves Douet1, Alvina Huor1, Hervé Cassard1, Séverine Lugan1, Naima Aron1, Mark Arnold2, Didier Vilette1, Juan-Maria Torres3, James W Ironside4, Olivier Andreoletti5.   

Abstract

Sporadic Creutzfeldt-Jakob disease (sCJD) is the commonest human prion disease, occurring most likely as the consequence of spontaneous formation of abnormal prion protein in the central nervous system (CNS). Variant Creutzfeldt-Jakob disease (vCJD) is an acquired prion disease that was first identified in 1996. In marked contrast to vCJD, previous investigations in sCJD revealed either inconsistent levels or an absence of PrPSc in peripheral tissues. These findings contributed to the consensus that risks of transmitting sCJD as a consequence of non-CNS invasive clinical procedures were low. In this study, we systematically measured prion infectivity levels in CNS and peripheral tissues collected from vCJD and sCJD patients. Unexpectedly, prion infectivity was detected in a wide variety of peripheral tissues in sCJD cases. Although the sCJD infectivity levels varied unpredictably in the tissues sampled and between patients, these findings could impact on our perception of the possible transmission risks associated with sCJD.

Entities:  

Year:  2021        PMID: 33532912      PMCID: PMC7882550          DOI: 10.1007/s00401-021-02270-x

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  55 in total

1.  Inactivation of the BSE agent.

Authors:  David Taylor
Journal:  C R Biol       Date:  2002-01       Impact factor: 1.583

2.  Sporadic Creutzfeldt-Jakob disease.

Authors:  Inga Zerr; Piero Parchi
Journal:  Handb Clin Neurol       Date:  2018

3.  An alternative approach to the optimal design of an LD50 bioassay.

Authors:  R A Markus; J Frank; S Groshen; S P Azen
Journal:  Stat Med       Date:  1995-04-30       Impact factor: 2.373

4.  Defining sporadic Creutzfeldt-Jakob disease strains and their transmission properties.

Authors:  Matthew T Bishop; Robert G Will; Jean C Manson
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-14       Impact factor: 11.205

5.  Evidence for zoonotic potential of ovine scrapie prions.

Authors:  Hervé Cassard; Juan-Maria Torres; Caroline Lacroux; Jean-Yves Douet; Sylvie L Benestad; Frédéric Lantier; Séverine Lugan; Isabelle Lantier; Pierrette Costes; Naima Aron; Fabienne Reine; Laetitia Herzog; Juan-Carlos Espinosa; Vincent Beringue; Olivier Andréoletti
Journal:  Nat Commun       Date:  2014-12-16       Impact factor: 14.919

6.  Age at onset of genetic (E200K) and sporadic Creutzfeldt-Jakob diseases is modulated by the CYP4X1 gene.

Authors:  Anna Poleggi; Sven van der Lee; Sabina Capellari; Maria Puopolo; Anna Ladogana; Eleonora De Pascali; Debora Lia; Alessia Formato; Anna Bartoletti-Stella; Piero Parchi; Cornelia van Duijn; Maurizio Pocchiari
Journal:  J Neurol Neurosurg Psychiatry       Date:  2018-07-21       Impact factor: 10.154

7.  Biochemical and physical properties of the prion protein from two strains of the transmissible mink encephalopathy agent.

Authors:  R A Bessen; R F Marsh
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

8.  Prion seeding activity and infectivity in skin samples from patients with sporadic Creutzfeldt-Jakob disease.

Authors:  Christina D Orrú; Jue Yuan; Brian S Appleby; Baiya Li; Yu Li; Dane Winner; Zerui Wang; Yi-An Zhan; Mark Rodgers; Jason Rarick; Robert E Wyza; Tripti Joshi; Gong-Xian Wang; Mark L Cohen; Shulin Zhang; Bradley R Groveman; Robert B Petersen; James W Ironside; Miguel E Quiñones-Mateu; Jiri G Safar; Qingzhong Kong; Byron Caughey; Wen-Quan Zou
Journal:  Sci Transl Med       Date:  2017-11-22       Impact factor: 17.956

9.  Highly efficient prion transmission by blood transfusion.

Authors:  Olivier Andréoletti; Claire Litaise; Hugh Simmons; Fabien Corbière; Séverine Lugan; Pierrette Costes; François Schelcher; Didier Vilette; Jacques Grassi; Caroline Lacroux
Journal:  PLoS Pathog       Date:  2012-06-21       Impact factor: 6.823

10.  Pathogenesis of experimental bovine spongiform encephalopathy (BSE): estimation of tissue infectivity according to incubation period.

Authors:  Mark Edward Arnold; Stephen Anthony Charles Hawkins; Robert Green; Ian Dexter; Gerald Arthur Henry Wells
Journal:  Vet Res       Date:  2008-10-28       Impact factor: 3.683

View more
  4 in total

Review 1.  Non-human primates in prion diseases.

Authors:  Emmanuel E Comoy; Jacqueline Mikol; Jean-Philippe Deslys
Journal:  Cell Tissue Res       Date:  2022-06-04       Impact factor: 5.249

Review 2.  The risk of Creutzfeldt-Jakob disease infection in cadaveric surgical training.

Authors:  Keiko Ogami-Takamura; Kazunobu Saiki; Daisuke Endo; Kiyohito Murai; Toshiyuki Tsurumoto
Journal:  Anat Sci Int       Date:  2022-03-21       Impact factor: 1.741

3.  Glycans are not necessary to maintain the pathobiological features of bovine spongiform encephalopathy.

Authors:  Alicia Otero; Tomás Barrio; Hasier Eraña; Jorge M Charco; Marina Betancor; Carlos M Díaz-Domínguez; Belén Marín; Olivier Andréoletti; Juan M Torres; Qingzhong Kong; Juan J Badiola; Rosa Bolea; Joaquín Castilla
Journal:  PLoS Pathog       Date:  2022-10-07       Impact factor: 7.464

4.  Prion strains associated with iatrogenic CJD in French and UK human growth hormone recipients.

Authors:  Jean-Yves Douet; Alvina Huor; Hervé Cassard; Séverine Lugan; Naïma Aron; Chloé Mesic; Didier Vilette; Tomás Barrio; Nathalie Streichenberger; Armand Perret-Liaudet; Marie-Bernadette Delisle; Patrice Péran; Jean-Philippe Deslys; Emmanuel Comoy; Jean-Luc Vilotte; Katayoun Goudarzi; Vincent Béringue; Marcelo A Barria; Diane L Ritchie; James W Ironside; Olivier Andréoletti
Journal:  Acta Neuropathol Commun       Date:  2021-08-28       Impact factor: 7.801

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.